In a study of the Danish asthma registry, decreasing Feno was found to be a predictor for remission in a cohort receiving anti-IL5/IL-5Rα therapy; however, decreasing Feno was not a predictor of remission in our cohort.40 The gene discussed is IL5; the disease is asthma.